[PDF] Top 20 Breast Cancer: An Update

... Two major groups have studies in prog- ress: the National Surgical Adjuvant Breast Proj- ect (NSABP) and the National Tumor Institute in Milan. Bene- fit was seen in p[r] ... See full document

... in cancer recurrences demonstrated by Demicheli are not readily seen in long-term follow-up data in patients treated with current treatment ...in breast cancer mortality rates and recurrence ...of ... See full document

... trial update consists of a review of two of eight current studies (the 10981-22023 AMAROS trial and the 10994 p53 trial) of the European Organization for Research and Treatment of Cancer Breast ... See full document

... with breast cancer die of the disease ...of cancer death in less developed regions, causing one in five deaths in African women [3], described as a new “shift” from the previous decade ...[4]. ... See full document

... Another strategy involves combining hormonal therapy with angiogenesis inhibitors. Angiogenesis, or the formation of new blood vessels, is critical to tumor growth and is principally mediated via tumoral secretion of ... See full document

... locally recurrent or metastatic breast cancer [30]. A pro- tocol amendment made the use of bevacizumab optional; however, 97% of patients had already received bevaci- zumab at that time. The majority (93%) ... See full document

... (table 2). The interim analysis reported at the 2016 San Antonio Breast Cancer Symposium revealed a 33.3% ORR (ranging between 27.3% in patients pretreated with one to two therapies to 41.2% in untreated ... See full document

... Male breast cancer (MBC) is a rare disease compared with female breast cancer ...to breast cancer (BC) in women, MBC is likely to be caused by the concurrent effects of different ... See full document

... This was a landmark study for patients with MBC and for eribulin. Critically, this was the first study to show a benefit in overall survival for any new therapy in heavily pretreated patients with MBC. It has been ... See full document

... for breast cancer risk reduction include a history of deep venous thrombosis or pulmonary embolism, a history of stroke or transient ischemic attack, a history of uncontrolled diabetes or hypertension ... See full document

... on Cancer; IGF-1: Insuling growth factor-1; IVF: In vitro fertilization; LAN: Light-at-night; MEHP: Mono(2-ethylhexyl)phthalate; MMP: Monomethyl phthalate; NAT2: N- acetyltransferase 2; NCI: National Cancer ... See full document

... receptor-positive, breast cancer, showing improved response rates and time to ...contralateral breast cancer over tamoxifen when used in the adjuvant ... See full document

... inflammatory breast cancer xenograft WIBC-9, originating from a patient with IBC, frequently metastasized and induced erythema of the overlying skin, like MARY-X and human IBC ... See full document

... with epirubicin, an anthracycline associated with good response in breast cancer and also having decreased cardiac toxicity relative to doxorubicin. Again, all these women were anthracycline-pretreated but ... See full document

... primary breast cancer after neoadjuvant ...International Breast Cancer Study Groups: BIG 1-98 Collaborative and Interna- tional Breast Cancer Study ...early breast ... See full document

... Breast cancer is the foremost common malignancy among the female population around the ...Female breast cancer incidence rates have increased since 1980, slowed in 1990, the rate of increase ... See full document

... is involved in several mechanisms essential in recovering from DNA damage and cancer growth. PARP inhibitors, in monotherapy or combined with chemo and or radiotherapy are therefore promising novel drugs that may ... See full document

... HaploReg showed that the G to T nucleotide change of rs1011970 altered the binding ability of three important cell cycle regulators (FOXO4, TFC12 and p300), possibly altering CDKN2B regulation. This hypothesis is ... See full document

... human breast cancer cell lines T47D and MDA-MD-231 were cultured in RPMI 1640 (Invitrogen, Carlsbad, CA, USA), and the human breast cancer cell line MCF-7 and the osteosarcoma cell line MG-63 ... See full document

... Australian Breast Cancer Family Study; ABCS, Amsterdam Breast Cancer Study; BBCC, Bavarian Breast Cancer Cases and Controls; BBCS, British Breast Cancer Study; ... See full document